![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TM6SF2 |
Gene summary for TM6SF2 |
![]() |
Gene information | Species | Human | Gene symbol | TM6SF2 | Gene ID | 53345 |
Gene name | transmembrane 6 superfamily member 2 | |
Gene Alias | TM6SF2 | |
Cytomap | 19p13.11 | |
Gene Type | protein-coding | GO ID | GO:0006629 | UniProtAcc | Q8N8A7 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
53345 | TM6SF2 | Pat01-B | Human | Stomach | GC | 1.03e-26 | 4.80e-01 | 0.5754 |
53345 | TM6SF2 | Pat02-B | Human | Stomach | GC | 9.13e-06 | 1.33e-01 | 0.0368 |
53345 | TM6SF2 | Pat03-B | Human | Stomach | GC | 8.94e-22 | 4.53e-01 | 0.3693 |
53345 | TM6SF2 | Pat17-B | Human | Stomach | GC | 1.55e-13 | 3.38e-01 | 0.3109 |
53345 | TM6SF2 | Pat19-B | Human | Stomach | GC | 3.24e-02 | 1.49e-01 | 0.0826 |
53345 | TM6SF2 | SIM_1 | Human | Stomach | SIM | 2.00e-06 | 2.56e-01 | 0.3573 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0055088 | Stomach | GC | lipid homeostasis | 24/1159 | 167/18723 | 9.86e-05 | 2.00e-03 | 24 |
GO:0019216 | Stomach | GC | regulation of lipid metabolic process | 37/1159 | 331/18723 | 3.67e-04 | 5.70e-03 | 37 |
GO:00192161 | Stomach | SIM | regulation of lipid metabolic process | 27/708 | 331/18723 | 1.58e-04 | 3.50e-03 | 27 |
GO:00550881 | Stomach | SIM | lipid homeostasis | 16/708 | 167/18723 | 6.11e-04 | 9.21e-03 | 16 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TM6SF2 | SNV | Missense_Mutation | novel | c.886N>T | p.Pro296Ser | p.P296S | Q9BZW4 | protein_coding | tolerated(0.19) | possibly_damaging(0.752) | TCGA-44-3918-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | SD |
TM6SF2 | SNV | Missense_Mutation | c.961N>G | p.Arg321Gly | p.R321G | Q9BZW4 | protein_coding | deleterious(0) | probably_damaging(0.95) | TCGA-55-8092-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
TM6SF2 | SNV | Missense_Mutation | rs374302893 | c.857N>T | p.Ala286Val | p.A286V | Q9BZW4 | protein_coding | deleterious(0) | possibly_damaging(0.572) | TCGA-69-7764-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
TM6SF2 | SNV | Missense_Mutation | rs371823523 | c.175G>T | p.Val59Phe | p.V59F | Q9BZW4 | protein_coding | tolerated(0.7) | benign(0.011) | TCGA-95-7567-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | SD |
TM6SF2 | SNV | Missense_Mutation | c.634N>A | p.Leu212Ile | p.L212I | Q9BZW4 | protein_coding | tolerated(0.09) | benign(0.007) | TCGA-97-A4M7-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
TM6SF2 | SNV | Missense_Mutation | novel | c.916N>C | p.Ile306Leu | p.I306L | Q9BZW4 | protein_coding | tolerated(0.97) | benign(0.003) | TCGA-22-1002-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
TM6SF2 | SNV | Missense_Mutation | c.895N>C | p.Ala299Pro | p.A299P | Q9BZW4 | protein_coding | deleterious(0) | possibly_damaging(0.8) | TCGA-43-2581-01 | Lung | lung squamous cell carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD | |
TM6SF2 | SNV | Missense_Mutation | novel | c.232N>T | p.Asp78Tyr | p.D78Y | Q9BZW4 | protein_coding | deleterious(0) | possibly_damaging(0.819) | TCGA-43-7656-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
TM6SF2 | SNV | Missense_Mutation | c.385G>T | p.Gly129Cys | p.G129C | Q9BZW4 | protein_coding | deleterious(0.02) | probably_damaging(0.965) | TCGA-56-7222-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | PD | |
TM6SF2 | SNV | Missense_Mutation | rs771340141 | c.592C>T | p.Arg198Cys | p.R198C | Q9BZW4 | protein_coding | tolerated(0.24) | benign(0) | TCGA-G9-7519-01 | Prostate | prostate adenocarcinoma | Male | <65 | 7 | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |